Please login to the form below

roxadustat

This page shows the latest roxadustat news and features for those working in and with pharma, biotech and healthcare.

First-line ovarian approval cements AZ’s Lynparza lead

And in another positive development, AZ also announced today that two additional phase 3 trials of its just-approved drug for anaemia in chronic kidney disease patients – roxadustat – backed the efficacy

Latest news

China first market to approve AZ’s kidney drug roxadustat

Roxadustat was compared to treatment with epoetin alfa over 26 weeks, matching the ESA’s efficacy in achieving a significant increase in haemoglobin levels. ... AZ and FibroGen have rights to roxadustat in the US, China and other world markets, while
AZ, FibroGen's anaemia drug on course for first filing this year

Roxadustat works by turning on the body's machinery for producing red blood cells that is usually stimulated by reduced oxygen levels in the blood. ... In addition, use of roxadustat is free of the burden of cold-chain storage and maintaining sterility,
GSK starts late-stage trials of daprodustat

administration.". GSK is in a race to market with other HIF-PHI developers, including FibroGen, which has a candidate called roxadustat (FG-4592) in late-stage trials in China for anaemia ... FibroGen said recently it is on track to file a marketing
AZ boosts cardio-renal portfolio with $2.7bn ZS Pharma buy

ZS-9 alongside drugs such as roxadustat, which is currently in phase III testing for anaemia associated with CKD.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

China: AstraZeneca’s new engine for growth and innovation

Roxadustat is under accelerated review and, if approved, would also be the first locally- developed medicine to hit the Chinese market even before Europe and the US,” says Mallon. ... Finally, a data readout for roxadustat is expected by the end of 2018

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Project Manager - Digital Healthcare - London: Excellent Remuneration Package

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Editorial / Copy Lead – Healthcare Advertising – Central London...: Salary TBC

Account Manager / Senior Account Manager - Healthcare Advertisin...: Excellent Remuneration

Senior Medical Writer: Competitive salary and benefits

PR Associate Director – Consumer Health & Beauty: Salary TBC

Freelance Medical Writer - Healthcare Advertising - London: Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day

Home-based Principal Medical Writer – Medical Comms: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Editor – Medical Education Agency – Bucks: Salary TBC

Senior / Principal Medical Writer - MedComms - Home Based / Vari...: Excellent Remuneration Packages

Hybrid Role - Principal Medical Writer / Account Handler - Publi...: Salary TBC

Experienced / Senior Account Director - Publications - London: Up to £80, 000 plus great benefits

Senior Account Manager- Pharma and Life Scienes: Competitive salary and benefits

Director – Healthcare PR: Salary TBC

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior Medical Writer: Salary TBC

Editorial/ Medical Director – Med Ed & Comms – Home-based...: Salary TBC

Project Manager - Medical Communications – South Wales: Excellent Remuneration Package

Senior Account Director/ Associate Director- Pharma and Life Sci...: Competitive salary and benefits

Account Director, Medical Education: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality: How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA: Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad: Six behaviours separate the good brand teams from the bad...